626
Participants
Start Date
July 31, 2004
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Immunotherapy with allogeneic prostate vaccine
Immunotherapy with allogeneic prostate vaccine
Chemotherapy (Taxotere and prednisone)
Chemotherapy (Taxotere and prednisone)
Akademiska University Hospital, Uppsala
der Technischen Universitat Dresden, Dresden
University Hospital Antwerp (UZA), Edegem
Imelda Ziekenhuis, Bonheiden
UZ Gent, Ghent
Columbia University Medical Center, New York
Jacobi Medical Center, The Bronx
Institut Paoli-Calmettes, Marseille
SUNY Upstate Medical University, Syracuse
Centre Francois Baclesse, Caen
University of Pittsburgh Cancer Center, Pittsburgh
Lancaster Cancer Center, Ltd, Lancaster
Urological Associates of Lancaster, Lancaster
Medical Oncology Associates, Kingston
Urologic Surgery PC, Bala-Cynwyd
Johns Hopkins University, Baltimore
Frederick Memorial Hospital Regional Cancer Therapy Center, Frederick
Virginia Oncology Associates, Norfolk
Presbyterian Hospital/ Center for Cancer Research, Charlotte
Northwestern Carolina Hematology Oncology, PA, Hickory
Charleston Hematology Oncology, Charleston
Atlanta VAMC, Atlanta
Georgia Cancer Specialists, Atlanta
Peachtree Hematology Oncology Consultants, PC, Atlanta
Winship Cancer Institute, Emory University, Atlanta
Central Georgia Cancer Care, P.C., Macon
Integrated Community Oncology Network, Jacksonville
Oncology-Hematology Group of South Florida/Advanced Medical Specialists, Miami
Michael and Dianne Bienes Comprehensive Cancer Center, Holy Cross Hospital, Fort Lauderdale
Boca Raton Community Hospital, Inc., Boca Raton
Urology Consultants, Safety Harbor
Cancer Centers of Florida, Ocoee
Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Central Alabama Oncology, LLC, Alabaster
Memorial Health Care System, Chattanooga
The West Clinic, Memphis
Cleveland Clinic Foundation, Taussig Cancer Center, Cleveland
Gabrail Cancer Center, Canton
Centre Rene Gauducheau, Nantes-Saint Herblain
Universitatsklinik um Essen, Essen
Fort Wayne Medical Oncology/Hematology Inc., Fort Wayne
Welborn Clinic Research Center, Evansville
Newland Medical Associates, P.C., Southfield
Centre Paul Papin, Angers
West Michigan Regional Cancer and Blood Center, Free Soil
Institut Jean Godinot, Reims
Universitatsklinikum Aachen Urologie, Aachen
Centre Alexis Vautrin, Vandœuvre-lès-Nancy
Dakota Cancer Institute, Fargo
Medcenter One Cancer Care / Odyssey Research, Bismarck
Deaconess Billings Clinic, Billings
Hematology/Oncology Centers of the Northern Rockies, P.C., Billings
University of Illinois at Chicago, Chicago
Hematology Oncology Consultants, Inc., St Louis
Universitatsklinik um des Saarlande, Homburg/Saar
Omaha VA Medical Center, Omaha
Louisiana Oncology Associates, Lafayette
Arkansas Cancer Research Center, Little Rock
University of Oklahoma, Oklahoma City
Mary Crowley Medical Research Center, Dallas
Center for Oncology Research and Treatment PA, Dallas
Urology Specialists and Associates, P.A., Dallas
Tyler Cancer Center, Tyler
Mobley Research Center, Houston
Centre Georges Francois Leclerc, Dijon
Urology San Antonio, San Antonio
The Don and Sybil Harrington Cancer Center, Amarillo
Univ. of Colorado Health Science Center, Aurora
Cancer Center of Colorado Springs, Colorado Springs
Mayo Clinic Scottsdale, Scottsdale
Palo Verde Hematology/Oncology, Glendale
ACRC/Arizona Clinical Res. Ctr. Inc., Tuscon
Oncology Care Medical Associates, Montebello
Center for Urological Research, La Mesa
San Diego Cancer Center, Vista
Sharp Healthcare, San Diego
San Bernardino Urological Associates, San Bernardino
Pacific Coast Hem Onc. Medical Group, Fountain Valley
UC Irvine Medical Center, Orange
Compassionate Cancer Care Medical Group, Inc., Corona
California Pacific Medical Center, San Francisco
California Cancer Care, Greenbrae
Cancer Research & Prevention Center, Soquel
Straub Clinic & Hospital, Honolulu
Providence Portland Medical Center, Portland
Virginia Mason Medical Center Urology, Seattle
Seattle Cancer Care Alliance, Seattle
Alaska Clinical Research Center, Anchorage
The Hope Clinic, Bristol
Urology Center of Grove Hill, New Britain
Carl & Dorothy Bennett Cancer Center, Stamford
William Beaumont Hospital, Cancer Clinical Trials Office, Royal Oak
Omaha VA Medical Center, Omaha
Dartmouth-Hitchcock Medical Center, Lebanon
The Center for Cancer & Hematologic Disease, Cherry Hill
Hematology-Oncology Associates of Northern New Jersey, Morristown
Summit Medical Group/Overlook Oncology Center, Summit
Southwestern Oncology Research Department, Bennington
ZNA Middelheim, Antwerp
Unversity Hospial Gent, Ghent
Virga Jesse Ziekenhuis, Hasselt
AZ Groeninge, Kortrijk
Heilig Hartziekenhuis Roeselare Men, Roeselare
Regionaal Ziekenhuis Sint Trudo, Sint-Truiden
Princess Margaret Hospital, Toronto
CHUM Notre-Dam, Montreal
McGill University, Montreal
Ultra Med Inc., Pointe-Claire
Centre Hopitalier Universitaire de Sherbrooke, Sherbrooke
Centre Leon Berard Service de Cancerologie Medicale, Lyon
VU Medisch Centrum, Amsterdam
University Medical Centre Groningen, Groningen
University Hospital, Linkoping, Linköping
University Hospital Lund, Lund
Addenbrooke's Hospital, Cambridge
Beatson Oncology Centre, Glasgow
St. James's University Hospital, Leeds
Hammersmith Hospital, London
Mount Vernon Hospital, Middlesex
Newcastle General Hospital, Newcastle upon Tyne
Northampton General Hosptial, Northampton
Nottingham City Hospital, Nottingham
Oxford Cancer Centre, Churchill Hospital, Oxford
Scunthorpe General Hospital, Scunthorpe
Royal Hallamshire Hospital, Sheffield
Glan Clwyd Hospital, Wales
Lead Sponsor
Cell Genesys
INDUSTRY